Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 22, 2025, 13:37
Pregnancy in Sickle Cell Disease: Addressing the Underrecognized Risk of Venous Thromboembolism
American Society of Hematology shared a post on LinkedIn:
“Pregnancy in sickle cell disease carries a high risk of thrombotic complications, yet guidance on anticoagulation remains inconsistent.
Chronic hypercoagulability and prior thrombotic events heighten these risks, making early recognition, individualized care, and preventive strategies essential.
Collaborative, multidisciplinary approaches and evidence-based anticoagulation protocols can help improve outcomes for this vulnerable population.”
Title: Venous Thromboembolism in Sickle Cell Disease: A Critical and Underrecognized Maternal Health Risk
Authors: Sacha Choupa
Read the full article here.
Stay updated with Hemostasis Today.
-
Apr 10, 2026, 18:22Chris Hillis: Reflections on My Term as President of the Canadian Hematology Society
-
Apr 10, 2026, 17:59Michelle Leona Cecil: Representing Microhealth at The Coalition for Hemophilia B Annual Symposium
-
Apr 10, 2026, 17:47Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
-
Apr 10, 2026, 17:39Diverse Voices But Shared Mission – Day 1 of EHC Youth Leadership Workshop
-
Apr 10, 2026, 17:30Make Your Mark at the World Stroke Congress 2026 – World Stroke Organization
-
Apr 10, 2026, 17:23Sofie Abels: Implications for Targeted Screening for Thrombophilia in Young Stroke Patients
-
Apr 10, 2026, 17:08Armghan Ans: 3 Questions Worth Sitting with If You Work in Stroke AI
-
Apr 10, 2026, 17:03William Wallace: Vitamin C Is More Than ”Immune Support”
-
Apr 10, 2026, 16:58Wolfgang Miesbach: Greater Symptom Burden in Women with Bleeding Disorders – Insights from Irish Data